Clinical Trials Directory

Trials / Completed

CompletedNCT03209661

Vascular Effects of a Single Bout of Electronic Cigarette Use

Status
Completed
Phase
Phase 1
Study type
Interventional
Enrollment
16 (actual)
Sponsor
University of Texas at Austin · Academic / Other
Sex
All
Age
20 Years – 30 Years
Healthy volunteers
Accepted

Summary

Investigating the acute effects of a single use E-Cigarette upon vascular health.

Detailed description

Subjects will inhale e-cigarettes of 5.4%, 0%, and sham menthol inhaler to determine the effects upon to measures of vascular health. These measures will include Cardio-Ankle Vascular Index and Flow Mediated Dilation.

Conditions

Interventions

TypeNameDescription
DRUGE-cigaretteE-Cigarette containing 5.4% nicotine will be administered to determine the effects on vascular function.
DRUGNicotine 0%E-Cigarette containing 0% nicotine will be administered to determine the effects on vascular function.
DRUGMenthol Inhalant ProductMenthol inhaler will be administered to determine the effects on vascular function.

Timeline

Start date
2017-04-28
Primary completion
2018-08-01
Completion
2018-08-31
First posted
2017-07-06
Last updated
2018-10-11

Locations

1 site across 1 country: United States

Regulatory

Source: ClinicalTrials.gov record NCT03209661. Inclusion in this directory is not an endorsement.